IMPAX Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.07.17	Pharma Stocks Taking Measures to Boost Growth (PR Newswire)
06.07.17	Pharma Stocks Taking Measures to Boost Growth (PR Newswire)
05.07.17	Impax Announces FDA Approval and Launch of Additional Strengths of Generic Focalin XR® (Dexmethylphenidate Hydrochloride) Extended-Release Capsules CII (PR Newswire)
26.06.17	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Impax Laboratories, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors (PR Newswire)
08.06.17	Impax to Present at the Goldman Sachs 38th Annual Global Healthcare Conference (PR Newswire)
02.06.17	Research Reports Initiation on Drug Makers Stocks -- Immune Pharma, Impax Labs, Heron Therapeutics, and Alimera Sciences (PR Newswire)
17.05.17	Impax to Present at the UBS Global Healthcare Conference (PR Newswire)
11.05.17	Impax to Present at the Bank of America Merrill Lynch Healthcare Conference (PR Newswire)
11.05.17	Gainers & Losers Of May 10: CUR, TEAR, PRTO, CXRX, DERM... (RTTNews)
10.05.17	Impax Reports First Quarter 2017 Financial Results (PR Newswire)
05.05.17	Genzyme Corporation Pays $5.885 Million To Resolve False Claims Act Allegations; Judgment Involving Cases Against Nine Other Pharmaceutical Manufacturers Certified As Final Judgment, Allowing Appeal (PR Newswire)
04.05.17	Chesapeake Utilities Corporation To Expand Natural Gas Service Territory In Florida (PR Newswire)
26.04.17	Impax Announces FDA Approval and Launch of a Generic Version of Vytorin® (Ezetimibe/Simvastatin Tablets) (PR Newswire)
21.04.17	Impax to Present Data on Rytary® (Carbidopa and Levodopa) Extended-Release Capsules, Zomig® (Zolmitriptan) Nasal Spray and Investigational Drug IPX203 at the 2017 American Academy of Neurology®... (PR Newswire)
19.04.17	Research Reports Initiation on Drug Makers Stocks -- Impax Labs, Sanofi, Heron Therapeutics, and Alimera Sciences (PR Newswire)
07.04.17	Muskingum University Installs Dr. Susan S. Hasseler As Its 21st President (PR Newswire)
06.04.17	Impax to Report First Quarter 2017 Results on May 10, 2017 (PR Newswire)
31.03.17	AEZS One Step Closer, AKTX To Report Data In April, CBIO On The Move (RTTNews)
30.03.17	Impax Announces Favorable Ruling Regarding Patent Validity for Zomig® (zolmitriptan) Nasal Spray (PR Newswire)
28.03.17	Tendon Repair and Regenerative Biomedicine Market Fastest Growing Segment in Tissue Engineering Segment (PR Newswire)
28.03.17	Tendon Repair and Regenerative Biomedicine Market Fastest Growing Segment in Tissue Engineering Segment (PR Newswire)
28.03.17	Gainers & Losers Of Mar.27: APOP, IPXL, ZIOP, FOMX... (RTTNews)
27.03.17	Impax Board of Directors Appoints Paul M. Bisaro President and CEO (PR Newswire)
14.03.17	How These Drug Makers Stocks are Faring? -- Sanofi, Impax Laboratories, Heron Therapeutics, and GW Pharma (PR Newswire)
07.03.17	Biotech and Pharma Stocks Rise on Optimism in the Markets Fueling Acquisitions and new Product Launches (PR Newswire)
07.03.17	Biotech and Pharma Stocks Rise on Optimism in the Markets Fueling Acquisitions and new Product Launches (PR Newswire)
02.03.17	Gainers & Losers Of Mar.1: DVAX, SKLN, FOLD, IPXL, QASM... (RTTNews)
01.03.17	Impax Reports Fourth Quarter and Full Year 2016 Financial Results (PR Newswire)
27.02.17	Impax to Present at Upcoming Investor Conferences (PR Newswire)
15.02.17	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Impax Laboratories, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors (PR Newswire)
06.02.17	Research Reports Coverage on Drug Makers Stocks -- Sanofi, Impax Labs, Heron Therapeutics, and Biostar Pharma (PR Newswire)
25.01.17	Impax to Report Fourth Quarter and Full Year 2016 Results on March 1, 2017 (PR Newswire)
13.01.17	CVS Offering Cheap Generic Alternative To EpiPen (RTTNews)
09.01.17	FinancialBuzz.com: Advances in Biotechnology Sector (PR Newswire)
06.01.17	Impax Confirms Patent Challenge Relating to Generic Aubagio® (teriflunomide) Tablets, 14 mg (PR Newswire)
03.01.17	EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Impax Laboratories, Inc. - IPXL (PR Newswire)
30.12.16	Research Reports Initiation on Drug Makers Stocks -- Aerie Pharma, Impax Laboratories, Retrophin, and GW Pharma (PR Newswire)
22.12.16	Impax Launches Generic Version of Kadian® (morphine sulfate) Extended Release Capsules, USP CII (PR Newswire)
22.12.16	SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Impax Laboratories Inc. To Contact The Firm Before Lead Plaintiff Deadline (PR Newswire)
21.12.16	IPXL INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Impax Laboratories, Inc. and a Lead Plaintiff Deadline of January 9, 2017 (PR Newswire)
20.12.16	Impax Laboratories Announces Leadership Transition (PR Newswire)
10.12.16	IMPAX SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against... (PR Newswire)
28.11.16	Impax Announces Appointment of J. Kevin Buchi to Board of Directors (PR Newswire)
22.11.16	Impax to Present at the 28th Annual Piper Jaffray Healthcare Conference (PR Newswire)
19.11.16	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investments Impax Laboratories Inc. of Class Action Lawsuit and Upcoming Deadline - IPXL (PR Newswire)
04.08.16	Impax Laboratories, Inc. -- Moody's assigns Ba2 rating to Impax's New Credit Facility; stable outlook (Moodys)
22.06.16	Impax Laboratories, Inc. -- Moody's: Impax's Debt-Funded Acquisition of Generics Products is Credit Negative (Moodys)
21.06.16	Impax Posting Steep Loss On Acquisition Of Generic Products (RTTNews)
21.06.16	Impax Labs To Acquire Generic Products; Lifts FY Adj. EPS Growth View (RTTNews)
19.01.16	FDA Delays Decision On HRTX Drug, Trial Woes Paint EBIO Red, NVLS On Watch (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu IMPAX Laboratories Inc.

Aktien Top/Flop

Meistgelesene Nachrichten